Close Menu
August 29, 2019
Sponsored by

Biobanking at Scale to Support Precision Medicine


Professor of Genetics, Rutgers University
COO, RUCDR Infinite Biologics, Human Genetics Institute of NJ

This webinar will outline how RUCDR Infinite Biologics, the world's largest university-based biorepository, has implemented workflows and processes to support precision medicine applications.

RUCDR Infinite Biologics, a unit of the Human Genetics Institute of New Jersey, has been perfecting the science of biobanking, bioprocessing, and analytics. In this webinar, Andrew Brooks will introduce how RUCDR Infinite Biologics has created novel workflows to address precision medicine applications and will present an overview of these workflows, cutting edge analytical approaches, and robust biomaterial storage processes.  

With a focus on primary sample processing and new technological innovations allowing for efficient and cost-effective nucleic acid extraction, he will describe how discovery processes are maximized, and precious biomaterial resources are protected for future analyses in both research and clinical applications.

Sponsored by

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.

Sponsored by
Qiagen: Nov 16, 2014

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Sponsored by

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Sponsored by

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.